FDA’s COVID-19 Activities
Learn about FDA’s regulatory pathways for the approval and investigation of products intended for the prevention and treatment of COVID-19. Understand actions that FDA has taken to assist industry during the COVID-19 pandemic. Learn about FDA COVID-19 enforcement.
Vanessa K. Burrows, Counsel, Simpson Thacher & Bartlett
This session was recorded as part of FDLI’s Introduction to Drug Law and Regulation Course in April 2022.
- +$100 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Virtual Learning FAQ